
Pascal Soriot
Executive Director and Chief Executive Officer, AstraZeneca
Executive Director and Chief Executive Officer, AstraZeneca
While at Roche, Pascal was in charge of integrating Genentech, the Californian biotech company, after a $47 billion takeover. He also led AstraZeneca in a successful defense against acquisition by Pfizer in 2014 – a feat few envisaged before he took the reins. He initially worked as a vet before embarking on his career in business.
False
False